baber/WOPTO huggingface dataset:
Patent DE-69409377-D1 (DE)
Inventor: NIEDERMANN HANS-PETER
IPC: A01N43/84
Filed: 1994-05-26
Granted: 1998-05-07
Abstract: PCT No. PCT/EP94/01758 Sec. 371 Date Apr. 25, 1996 Sec. 102(e) Date Apr. 25, 1996 PCT Filed May 26, 1994 PCT Pub. No. WO94/27983 PCT Pub. Date Dec. 8, 1994A compound of general formula (I) wherein: A represents a group of general formula (1) or (2) in which each X independently represents a halogen atom or an optionally substituted alkyl, cycloalkyl, alkoxy, aryl or aryloxy group, or an alkenyloxy, alkynyloxy, alkylthio, haloalkylthio, alkenylthio, alkynylthio, alkylsulphinyl, alkylsulphonyl or cyano group; and n is 0, an integer from 1 to 4, or, for the phenyl group, 5; or A represents a group of general formula (3) in which each of R4, R5 and R6 independently represents a hydrogen or halogen atom, an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, alkaryl alkoxy, amino, mono- or di-alkylamino, alkoxycarbonylamino, arylamino, dialkylcarbamoyl, acyl or acylamido group or a cyano group, with the proviso that R5 and R6 do not represent an acyl, acylamido or cyano group; Z represents an oxygen or sulphur atom; R1 and R2 each independently represents a hydrogen atom or an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, aryl, aralkyl, alkaryl, hydroxy, alkoxy, alkenyloxy, alkynyloxy, alkylcarbonyl, alkoxycarbonyl, amino, mono- or di-alkylamino, alkoxycarbonylamino, arylamino, arylalkylamino or dialkylcarbamoyl group, or together represent an alkylene chain which is optionally interrupted by an oxygen or sulphur atom or by a group -NR- in which R represents a hydrogen atom or an alkyl group; and R3 represents a hydrogen or halogen atom or an alkyl group.
Patent DE-69410644-D1 (DE)
Inventor: DODD GRAHAM SYDNEY
IPC: E06B3/70
Filed: 1994-01-11
Granted: 1998-07-09
Abstract: The invention relates to a door, a fanlight, door side section (door side light), window or similar, characterised by two glass sheets arranged beside one another at a distance, by a frame holding the sheets at a distance from one another - preferably incorporating fittings for the door etc., said frame essentially being covered by the sheets, by sealing means for the hermetic sealing of the space enclosed by frame between sheets and by a dessicant communicating with this space. <IMAGE>
Patent DE-69425653-D1 (DE)
Inventor: ENGELHARD ROLF
IPC: C02F1/32
Filed: 1994-04-05
Granted: 2000-09-28
Abstract: Water to be purified swirls about a source of ultraviolet radiation to kill any microorganisms contained therein and flows through a carbon filter cartridge mounted about the ultraviolet source to remove any chlorine and particulate matter. The outflow from the carbon filter is again subjected to ultraviolet radiation to kill any microorganisms entrained in the water emanating from the carbon filter. An ozone generator may be incorporated to entrain ozone with the inflowing water to enhance killing of any microorganisms present and to oxidize any undesirable compounds.
Patent DE-69426071-D1 (DE)
Inventor: VERIN DR
IPC: A61N5/10
Filed: 1994-06-24
Granted: 2000-11-09
Abstract: A balloon catheter comprises a catheter tube (31) surrounded distally by an elongated inflatable balloon (32) and a guidewire lumen (41) with an entry (42) and an exit (43) distal of the balloon (32) for accomodating a guidewire In the catheter tube (31) is a longitudinal lumen (33) for positioning a radioactive radiation emitter (35) within the balloon. The catheter comprises a second lumen (34) for directing inflation fluid into the balloon (32). Belt means (37) creating a waist are mounted on the balloon (32) to squeeze it down to nearly the diameter of the catheter (31) thereby leaving a small passage (38) for the inflation fluid. The belt means (37) divide the balloon into sections to assure a close center fit of the catheter (31) within the balloon. <IMAGE>
Patent DE-69428252-D1 (DE)
Inventor: RYDER THOMAS B
IPC: C12Q1/6865
Filed: 1994-07-21
Granted: 2001-10-18
Abstract: A method for amplification of a nucleic acid strand in a test sample. The method includes contacting the nucleic acid strand from the test sample simultaneously with at least three oligonucleotide primers. At least one primer is a promoter-primer, and at least one other primer is complementary to the nucleic acid strand, and one other primer is complementary to a strand complementary to the nucleic acid strand. The method further includes contacting the nucleic acid strand and primers with one or more proteins having RNA-directed and/or DNA-directed DNA polymerase activities, an RNA polymerase activity, and an RNAse H activity under primer-extension conditions to allow amplification of a target region in the nucleic acid strand at essentially constant temperature. <IMAGE>
Patent DE-69430317-D1 (DE)
Inventor: HARRIS MILTON
IPC: A61K47/48
Filed: 1994-11-14
Granted: 2002-05-08
Abstract: A poly(ethylene glycol) derivative is disclosed that is activated with a sulfone moiety for selective attachment to thiol moieties on molecules and surfaces. The activated PEG is water soluble, hydrolytically stable for extended periods, and forms hydrolytically stable linkages with thiol moieties. The linkages generally are not reversible in reducing environments. The PEG derivative is useful for modifying the characteristics of substances including modifying biologically active molecules and surfaces for biocompatibility. Methods for synthesizing the active PEG and for preparing conjugates of the active PEG and other substances, including biologically active substances, are also disclosed.
Patent DE-69431431-D1 (DE)
Inventor: CORNELL ANDREW
IPC: G01N27/333
Filed: 1994-04-20
Granted: 2002-10-31
Abstract: The present invention relates to a membrane for use in detecting the presence of an analyte. The membrane comprises an array of closely packed self-assembling amphiphilic molecules and a plurality of first and second receptor molecules, the first receptor molecules being reactive with one site on the analyte and second receptor molecules being reactive with another site on the analyte. The first receptor molecules are prevented from lateral diffusion within the membrane whilst the second receptor molecules are free to diffuse laterally within the membrane. The membrane is characterized in that the ratio of first receptor molecules to second receptor molecules is 10:1 or greater.
Patent DE-69435332-D1 (DE)
Inventor: ROSE ROBERT C
IPC: A61K35/64
Filed: 1994-03-08
Granted: 2011-02-17
Abstract: The present invention is directed to a method of expressing the papillomavirus capsid protein coding sequence in a cell using an expression system under conditions facilitating expression of the protein in the cell. In another aspect of the invention, it has been discovered that virus-like particle(s) (VLPs), fragment(s), capsomer(s) or portion(s) thereof are formed from the papillomavirus capsid
Patent DE-69510376-D1 (DE)
Inventor: LAPORTE JEAN-MICHEL
IPC: F41J9/18
Filed: 1995-12-08
Granted: 1999-07-22
Abstract: PCT No. PCT/FR95/01625 Sec. 371 Date Jun. 13, 1997 Sec. 102(e) Date Jun. 13, 1997 PCT Filed Dec. 8, 1995 PCT Pub. No. WO96/18864 PCT Pub. Date Jun. 20, 1996The apparatus is comprised of two launchers (6, 7) having the same technical characteristics, arranged next to each other. One of the launchers is symmetrical to the other one with respect to a vertical symmetry plane which separates them. Both launchers (6, 7) have their own launching ramp (8 and 9) and their launching arm (4, 5), each at a different level, and are mounted integrally with an oscillating plate (10). The oscillating plate (10) is mounted on an oscillation shaft (11) of a base plate (12) which forms the fixed base of the apparatus. The apparatus is used in sport shooting.
Patent DE-69514021-D1 (DE)
Inventor: SPRIET OLIVIER
IPC: A61J1/14
Filed: 1995-03-27
Granted: 2000-01-27
Abstract: The chassis of the machine (1) supports a fixed supply table with three successive conveyor belts (3,14,19). The belts are able to transfer sachets of blood to evacuation bottles at the other end of the machine. Two stations (4,20) are provided to read the codes and labels carried by the sachets of blood. They are arranged above the first and third conveyors respectively. The central conveyor includes a weighing unit (16). Two robots (9,14) are provided for applying labels to the sachets. <IMAGE>
Patent DE-69515907-D1 (DE)
Inventor: DAVIS FRANKLIN
IPC: G10L19/16
Filed: 1995-12-20
Granted: 2000-04-27
Abstract: A split-band perceptual coding system utilizes generalized waveform predictive coding in frequency bands to further reduce coded signal information requirements. The system including frequency subband each having a bandwidth commensurate with or less than a corresponding critical band of human perception. The order of the predictors are selected to balance requirements for prediction accuracy and rapid response time. Predictive coding may be adaptively inhibited in a band during intervals in which no predictive coding gain is realized.
Patent DE-69601675-D1 (DE)
Inventor: MORIZOT CHRISTIAN
IPC: A47C20/00
Filed: 1996-08-14
Granted: 1999-04-15
Abstract: The slatted mattress base has a back zone that can be raised and has a double head rest. This has a U-shaped frame (2) whose side bars (6) pivot on the mattress base. A second U-shaped frame (3) pivots on the first frame and moves telescopically on this when the back is raised.   The back is raised by pivoting arms (12) and rods (21) and a back part (45) is joined to the rods. When the back is lowered the bars of the frames (6,18) are axially aligned. Each bar of the second frame rests on a support (23) joined to the bar of the first frame.
Patent DE-69615713-D1 (DE)
Inventor: KRAFT NEIL
IPC: G08B15/00
Filed: 1996-03-04
Granted: 2001-11-08
Abstract: A computer based event capturing system and method allows the flexibility of capturing variable but unrelated lengths of video image sequences before an event, during an event and after an event. The event capturing system and method stores video images recorded during monitoring in a fixed number of files such that once the maximum number of files to be stored during monitoring has been reached, the oldest file is deleted and the newly captured video image file is stored in a new location in storage. Thus, storage of the files during monitoring has the appearance of a circular format. Video images recorded after the occurence of one or more events are stored in files in a linear format. The number of files stored in permanent storage from those recorded during monitoring is unrelated to the number of files stored after the event. In addition to being unrelated to the number of pre-event files permanently stored, the number of post-event files permanently stored is also unrelated to the total number of files corresponding to the video images captured before, during and after the event. The event capturing system and method also enables local and remote storage and playback capability of video images from multiple locations in an environment.
Patent DE-69619673-D1 (DE)
Inventor: GAUTIER JEAN-CLAUDE
IPC: A61K47/44
Filed: 1996-06-28
Granted: 2002-04-11
Abstract: PCT No. PCT/FR96/01010 Sec. 371 Date Mar. 13, 1998 Sec. 102(e) Date Mar. 13, 1998 PCT Filed Jun. 28, 1996 PCT Pub. No. WO97/02031 PCT Pub. Date Jan. 23, 1997The invention relates to a pharmaceutical composition for parenteral administration, characterized in that it comprises: from 1.5 to 8% by weight of an active principle consisting of amiodarone or one of the pharmaceutically acceptable salts thereof a physiologically acceptable buffer solution capable of solubilizing the active principle and of maintaining the pH of the composition between 2.4 and 3.8 a nonionic hydrophilic surfactant.
Patent DE-69623900-D1 (DE)
Inventor: VAN DER MEIJ PAULUS FRANCISCUS
IPC: A61K31/473
Filed: 1996-10-10
Granted: 2002-10-31
Abstract: The invention relates to a method for the preparation of an enantiomerically pure imidazolyl compound of the general formula <CHEM>  wherein:     n is 0 or 1;   m is 1 or 2;   R1 is hydrogen, methyl or ethyl; and   C* denotes a chiral centre;  as well as its pharmaceutically acceptable acid addition salt; by   a) adding a carboxylic acid in an optically active form to a solution of a racemic mixture of the above compound I, followed by separation of the crystallized acid addition salt of said mixture of enantiomers of compound I enriched in one enantiomer, from the mother liquor enriched in the other enantiomer b) when the crystallized acid addition salt is enriched in the undesired enantiomer, by then separating the mixture of enantiomers in the mother liquor from said optically active carboxylic acid, followed by addition of a racemic mixture of said carboxylic acid to a solution of the obtained mixture of isomers of I, and by separation of the crystallized acid addition salt of said mixture, enriched in the desired enantiomer, from the mother liquor, and (c) optionally recrystallizing the product until the desired enantiomeric purity is obtained, and by then (d) converting this acid-addition salt of the desired enantiomer to the desired enantiomerically pure imidazolyl compound of the general formula I or to its pharmaceutically acceptable acid addition salt, characterized in that pyroglutamic acid is used as said carboxylic acid. The invention further relates to a method of racemisation and to a new acid addition salt of this formula I compound and D-pyroglutamic acid.
Patent DE-69628838-D1 (DE)
Inventor: MCFADDEN GRANT
IPC: A61P31/04
Filed: 1996-04-19
Granted: 2003-07-31
Abstract: The present invention provides a method of use for a novel type I chemokine binding protein encoded by poxviruses and having amino acid sequence homology with the myxoma virus T7 interferon- gamma  receptor homolog against disease syndromes associated with acute or chronic dysregulated inflammatory responses.
Patent DE-69631592-D1 (DE)
Inventor: MULLER W
IPC: A61K31/40
Filed: 1996-08-29
Granted: 2004-03-25
Abstract: Novel nitriles are inhibitors of tumor necrosis factor  alpha  and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions. A typical embodiment is 3-Phthalimido-3-(3,4-dimcthoxyphenyl)propionitrile.
Patent DE-69633746-D1 (DE)
Inventor: MILES DALE A
IPC: H05G1/10
Filed: 1996-12-13
Granted: 2004-12-02
Abstract: A portable and preferably hand-held X-ray generator for use in intraoral and other X-ray applications, and a new process of dental image acquisition which utilizes a novel receptor holder physically linked to the lightweight, portable generator, and a unique, articulating arm and cradle which allows one generator to be used in multiple operatories. The system's generator has a reduced X-ray output and much smaller focal spot area than conventional dental X-ray generators, which reduces the X-ray output and the overall patient X-ray burden. The smaller focal spot also allows for improved resolution in the final image.
Patent DE-69634022-D1 (DE)
Inventor: HSU C-P SHERMAN
IPC: G01N30/04
Filed: 1996-02-28
Granted: 2005-01-20
Abstract: A method for enhancing detection sensitivity of suspected trace amounts of organic analytes and particularly semivolatile organic analytes extractable from a sample by an organic solvent carrier matrix and subsequent extraction and analysis of said trace organic analytes by SPME wherein the improvement comprises exchanging the organic solvent carrier matrix containing the trace organic analytes for an aqueous carrier matrix before performing SPME fiber extraction and detection of the trace organic analytes. The diagram, a chromatogram obtained with an ECD detector, illustrates the determination of chlorinated pesticides at the sub-parts per trillion level. <IMAGE>
Patent DE-69636917-D1 (DE)
Inventor: YANG YEASING
IPC: C12Q1/68
Filed: 1996-06-05
Granted: 2007-04-05
Abstract: The present invention discloses hybridization assay probes, amplification primers, nucleic acid compositions and methods useful for detecting Neisseria nucleic acids. Hybridization assay probes and amplification primers that selectively detect Neisseria meningitidis and distinguish those Neisseria meningitidis from Neisseria gonorrohoeae are disclosed. Other hybridization probes selectively detect Neisseria gonorrohoeae and not Neisseria meningitidis are also described.
Patent DE-69703477-D1 (DE)
Inventor: MC FARLANE GLEN
IPC: H01R24/84
Filed: 1997-04-30
Granted: 2000-12-14
Abstract: A connector unit 1 comprises a latching shell 3 having three peripheral resilient tongues 4 at substantially 120 DEG  from one another each bearing an outwardly projecting latch 5. A catching sleeve 28 also arranged in the connector unit 1 has three peripheral arms 30 at substantially 120 DEG  from one another each provided with an inner latch catching groove 31. The peripheral arms 30 of the catching sleeve 28 are located angularly between the resilient tongues 4 of the latching shell 3, whereby the latches 5 are circumferentially alternating with the latch catching grooves 31. <IMAGE>
Patent DE-69703621-D1 (DE)
Inventor: BERGAMASCHI GIOVANNI
IPC: E06B9/90
Filed: 1997-05-20
Granted: 2001-01-04
Abstract: PCT No. PCT/IB97/00572 Sec. 371 Date Nov. 23, 1998 Sec. 102(e) Date Nov. 23, 1998 PCT Filed May 20, 1997 PCT Pub. No. WO97/44563 PCT Pub. Date Nov. 27, 1997An assembly for locking a curtain in a selected position has a hollow roller unto which a curtain is rolled and unrolled, the roller containing an elastic winding device, and a locking device for locking the roller in the selected position. The locking device has a support coupled to the roller, the support having a cavity which receives co-axially and rotatably at least one locking element that has an elastic band which frictionally engages the support to hinder free rotation of the roller. The elastic band has a first end fastened to the locking element with the band wound around the locking element so that the band is in frictional contact with the support. Turning the roller in the curtain unrolling direction stretches the elastic band thus reducing the band diameter and reducing friction while turning the roller in the curtain rolling up direction in response to the elastic rewinding device increases the band diameter and increases friction so as to overcome the rewinding action and lock the curtain in the selected position.
Patent DE-69703964-D1 (DE)
Inventor: KERGEN RICHARD
IPC: B21D24/02
Filed: 1997-05-28
Granted: 2001-03-01
Abstract: PCT No. PCT/BE97/00063 Sec. 371 Date Aug. 17, 1998 Sec. 102(e) Date Aug. 17, 1998 PCT Filed May 28, 1997 PCT Pub. No. WO97/46337 PCT Pub. Date Dec. 11, 1997A stamping press comprising a blank-holder force-regulating system using fluid-operated compensating cylinders (5, 7). The variation in the force in the blank-holder pressure-regulating areas is thus compensated so as to maintain a predetermined constant pressure in the conventional blank-holder area. This pressure in the conventional blank-holder area can, by virtue of the invention, according to certain alternative embodiments, also be made to vary.
Patent DE-69704894-D1 (DE)
Inventor: DEVILLE ANTOINE
IPC: F16B7/14
Filed: 1997-02-03
Granted: 2001-06-28
Abstract: The system, e.g. for an extending telescopic pole or mast locked by rotation, consists of a central component (4) fixed to the end of one telescopic member (T1) and having a threaded section (42) which projects into the adjacent member (T2). The second member (T2) container two semi=cylindrical shells (50, 51) with wedge-shaped facing edges (501, 511). One of the shells has an inner rib to engage with the threaded section (42) and enable it to move relative to the other shell. When the shells are moved towards one another they expand and lock the two members of the pole, and when they are moved apart they release the members and allow them to be adjusted.
Patent DE-69709407-D1 (DE)
Inventor: SAULNIER GEORGE
IPC: A61P35/00
Filed: 1997-08-21
Granted: 2002-01-31
Abstract: The present invention concerns novel amino sugar and related sugar derivatives of indolopyrrolocarbazoles, their use as antitumor agents, and pharmaceutical formulations.
Patent DE-69722990-D1 (DE)
Inventor: FASCETTI EUGENIO
IPC: C12S1/02
Filed: 1997-03-07
Granted: 2003-07-31
Abstract: The invention relates to a strain of Arthrobacter sp. CBS 208.96 capable of selectively effecting the opening of the C-S bond of sulfurated organic molecules present in carbonaceous materials and its use in a process for the selective removal of organic sulfur from fossil fuels contained therein. <IMAGE>
Patent DE-69727919-D1 (DE)
Inventor: JAERVELAE MIKKO
IPC: H04B7/26
Filed: 1997-12-19
Granted: 2004-04-08
Abstract: The present invention relates to a method for allocating RAKE branches and a RAKE receiver. The solution is used in a radio system where a transmitter transmits a signal to a receiver comprising RAKE branches which receive the signal at different polarization levels. The RAKE branches are allocated to receive the signal on the basis of an impulse response, and in which method the impulse responses of the signals received at different polarization levels are weighted by values describing signal quality for optimizing allocation.
Patent DE-69733572-D1 (DE)
Inventor: THOMAS J
IPC: C12Q1/68
Filed: 1997-04-04
Granted: 2005-07-21
Abstract: The invention relates generally to the gene, and mutations thereto, that are responsible for the disease hereditary hemochromatosis (HH). More particularly, the invention relates to the identification, isolation, and cloning of the DNA sequence correspondence to the normal and mutant HH genes, as well as the characterization of their transcripts and gene products. The invention also relates to methods and the like for screening for HH homozygotes and further relates to HH diagnosis, prenatal screening and diagnosis, and therapies of HH disease, including gene therapeutics, protein and antibody based therapeutics, and small molecule therapeutics.
Patent DE-69736719-D1 (DE)
Inventor: SHARKEY J
IPC: A61F2/30
Filed: 1997-10-22
Granted: 2006-11-02
Abstract: Percutaneous methods and systems for treating an intervertebral disc are disclosed. An intervertebral disc treatment apparatus includes an introducer (12) and a catheter (14) having a distal end (28), a proximal end, a longitudinal axis, and an intradiscal section (16) at the distal end on which there is at least one functional element (29). The treatment proceeds by applying a force longitudinally to the proximal end of the catheter which is sufficient to advance the intradiscal section through the nucleus pulposus and around an inner wall of an annulus fibrosus, but which force is insufficient to puncture the annulus fibrosus. The functional element is positionned at a selected location of the intervertebral disc by advancing or retracting the catheter and optionally twisting the proximal end of the catheter. Then, the functional unit treats the intervertebral disc. Optionally, there is an additional step of aspirating and/or adding a substance to the intervertebral disc.
Patent DE-69805810-D1 (DE)
Inventor: DANNEELS ALLISON
IPC: A61K8/891
Filed: 1998-07-17
Granted: 2002-07-11
Abstract: A process for producing multi-layered tissue paper products with increased softness comprises the following process steps: production of layered webs of tissue paper, assembly of the layered webs to form a multi-layered web of product which is untreated with respect to softness, and printing of the web of product in the dry state with a softening lotion having the following minimum composition in percent by weight: a quaternary ammonium compound 3 to 30 %, siloxane foam suppressor 0.1 to 3.0 %, aloe vera powder 0.1 to 10 % a polyhydroxy softener, in particular polyethylene glycol 0.05 to 5 % remainder water.